Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?
Systematic imaging review: Multiple Sclerosis.
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions.
Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population.
Remyelination therapy goes to trial for multiple sclerosis.
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Development of a cross-cultural item bank for measuring quality of life related to mental health in multiple sclerosis patients.
Does Nrf2 help nerves to survive?
Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica.
Acute Bilateral Optic Neuritis in Active Ankylosing Spondylitis.
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis.
The Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells.
Upper Limb Rehabilitation in People With Multiple Sclerosis: A Systematic Review.
Cerebrospinal fluid proteomics: A new window for understanding human demyelinating disorders?
Rat white matter injury model induced by endothelin-1 injection: technical modification and pathological evaluation.
IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
656
657
658
659
660
661
662
663
664
…
next ›
last »